Baligh R. Yehia, MD, MPP, MSHP; Daniel Calder, MPH; Judd D. Flesch, MD; Rebecca L. Hirsh, MD; Eve Higginbotham SM, MD; Nancy Tkacs, PhD, RN; Beverley Crawford, DDS; Neil Fishman: Advancing LGBT Health at an Academic Medical Center: A Case Study LGBT Health 2 (4): 362-6,2015.
Hirsh RL: The role of lapatinib in the preoperative therapy of breast cancer Curr Oncol Rep. : 2012.
Hirsh RL: Duration of chemotherapy for early stage breast cancer: have we reached the limit? What is the survival impact of amenorrhea? Curr Treat Options Oncol. 11 (3-4): 59-62,2010.
Hirsh RL: HER2 blockade: is combination therapy better than monotherapy? Curr Treat Options Oncol. 11 (3-4): 63-5,2010.
Hirsh RL, Dilip G, Rogers G, Richard S: Langerhans cell histiocytosis following acute leukemia in an adult. American Journal of Hematology 84 (10): 693-4,2009.
Petrylak DP, Resto-Garces K, Tibyan M: Phase I Trial Evaluating Escalating Doses of Docetaxel and Lenalidomide J Clin Oncol 27 (15s (suppl)): 2009.
Hirsh RL: Current Therapeutic Options in Follicular Lymphoma. OncologyCases.com : 2008.
Hirsh RL American College of Physicians Regional Meeting : 2003.
Exertional Rhabdomyolysis in a Fit Prison Inmate American College of Physicians Regional Meeting : 2003.